ENZO BIOCHEM INC Business Finance Contracts & Agreements
16 Contracts & Agreements
- Credit Agreements (1 contract)
- Debenture Agreements (1)
- Escrow Agreements (1)
- Guarantee Agreements (1)
- Purchase Agreements (5)
- Registration Rights Agreements (1)
- Security Agreements (2)
- Stock Agreements (3)
- Warrant Agreements (1)
- Description of Capital Stock (Filed With SEC on November 3, 2023)
- Amendment No. 1 to Asset Purchase Agreement, dated as of July 3, 2023, by and among Enzo Biochem, Inc., Enzo Clinical Labs, Inc., and Laboratory Corporation of America Holdings (Filed With SEC on July 10, 2023)
- Form of Subsidiary Guarantee (Filed With SEC on May 22, 2023)
- Security Agreement, dated May 19, 2023, by and among Enzo Biochem, Inc., each of Enzo Biochem, Inc.s specified subsidiaries named therein, the purchasers named therein and JGB... (Filed With SEC on May 22, 2023)
- Registration Rights Agreement, dated May 19, 2023, by and among Enzo Biochem, Inc. and the purchasers named therein (Filed With SEC on May 22, 2023)
- Securities Purchase Agreement, dated May 19, 2023, by and among Enzo Biochem, Inc., the purchasers named therein, and JGB Collateral, LLC (Filed With SEC on May 22, 2023)
- Form of Warrant (Filed With SEC on May 22, 2023)
- Form of Debenture (Filed With SEC on May 22, 2023)
- Credit Agreement, dated as of March 31, 2023, by and among Enzo Clinical Labs, Inc., Enzo Life Sciences, Inc., Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL, Enzo... (Filed With SEC on April 5, 2023)
- Asset Purchase Agreement, dated as of March 16, 2023, by and among Laboratory Corporation of America Holdings, Enzo Clinical Labs, Inc. and Enzo Biochem, Inc (Filed With SEC on March 16, 2023)
- Purchase and Sale Agreement by and between Building Blocks Realty Co. LLC (seller) and Enzo Realty LLC (Purchaser) (Filed With SEC on October 15, 2018)
- THIRD AMENDMENT TO REVOLVING LOANAND SECURITY AGREEMENT (Filed With SEC on December 8, 2015)
- ESCROW AGREEMENT (Filed With SEC on June 23, 2014)
- ENZO BIOCHEM, INC. Up to $20,000,000 of Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 28, 2013)
- ASSET PURCHASE AGREEMENT by and among ENZO LIFE SCIENCES, INC., ENZO LIFE SCIENCES ACQUISITION, INC., ASSAY DESIGNS, INC., AMPERSAND 2001 LIMITED PARTNERSHIP and AMPERSAND 2001... (Filed With SEC on March 13, 2009)
- STOCK AND ASSET PURCHASE AGREEMENT by and among ENZO BIOCHEM, INC. ENZO LIFE SCIENCES, INC. BIOMOL INTERNATIONAL, INC. AXXORA (UK) LTD. BIOMOL INTERNATIONAL, L.P., BIOFINITI,... (Filed With SEC on May 9, 2008)
